These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16984797)

  • 1. Effects of antenatal betamethasone on maternal and fetoplacental matrix metalloproteinases 2 and 9 activities in human singleton pregnancies.
    Gharraee Z; Beharry KD; Valencia AM; Cho S; Guajardo L; Nageotte MP; Modanlou HD
    J Investig Med; 2006 Jul; 54(5):245-54. PubMed ID: 16984797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and feto-placental prostanoid responses to a single course of antenatal betamethasone.
    Cho S; Beharry KD; Valencia AM; Guajardo L; Nageotte MP; Modanlou HD
    Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):139-59. PubMed ID: 16303612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of a single course of antenatal betamethasone on the maternal-fetal insulin-IGF-GH axis in singleton pregnancies.
    Ahmad I; Beharry KD; Valencia AM; Cho S; Guajardo L; Nageotte MP; Modanlou HD
    Growth Horm IGF Res; 2006 Aug; 16(4):267-75. PubMed ID: 16920374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal betamethasone and chorioamnionitis induce different collagenases during lung maturation in fetal sheep.
    Sweet DG; Huggett MT; Warner JA; Moss TJ; Kloosterboer N; Halliday HL; Newnham JP; Kallapur SG; Jobe AH; Kramer BW
    Neonatology; 2008; 94(2):79-86. PubMed ID: 18264025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of activities of matrix metalloproteinases-9 and -2, and the tissue inhibitors of MMPs in fetal fluid compartments during gestation and at parturition in the mare.
    Oddsdóttir C; Riley SC; Leask R; Shaw DJ; Aurich C; Palm F; Fowden AL; Ricketts SW; Watson ED
    Theriogenology; 2011 Apr; 75(6):1130-8. PubMed ID: 21220153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of messenger RNA expression of matrix metalloproteinases (MMP-2 and MMP-9), tissue inhibitor-2 of matrix metalloproteinases (TIMP-2), and steroidogenic enzymes in bovine placentomes during gestation and postpartum.
    Takagi M; Yamamoto D; Ohtani M; Miyamoto A
    Mol Reprod Dev; 2007 Jul; 74(7):801-7. PubMed ID: 17154296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expressions of MMP-2, MMP-9, and TIMP-2 in placentas from women exposed to lead.
    González-Puebla E; González-Horta C; Infante-Ramírez R; Sanin LH; Levario-Carrillo M; Sánchez-Ramírez B
    Hum Exp Toxicol; 2012 Jul; 31(7):662-70. PubMed ID: 22241630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase release from placental explants of pregnancies complicated by intrauterine growth restriction.
    Merchant SJ; Crocker IP; Baker PN; Tansinda D; Davidge ST; Guilbert LJ
    J Soc Gynecol Investig; 2004 Feb; 11(2):97-103. PubMed ID: 14980311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinase (MMP)-2, MMP-14 and tissue inhibitor of matrix metalloproteinase (TIMP)-2 during bovine placentation and at term with or without placental retention.
    Dilly M; Hambruch N; Shenavai S; Schuler G; Froehlich R; Haeger JD; Ozalp GR; Pfarrer C
    Theriogenology; 2011 Apr; 75(6):1104-14. PubMed ID: 21247626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One percent of the clinical dose used for antenatal steroid therapy is sufficient to induce lung maturation when administered directly to the preterm ovine fetus.
    Fee EL; Takahashi T; Takahashi Y; Carter S; Furfaro L; Clarke MW; Milad MA; Usuda H; Newnham JP; Saito M; Jobe AH; Kemp MW
    Am J Physiol Lung Cell Mol Physiol; 2022 Jun; 322(6):L853-L865. PubMed ID: 35438005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases-2 and -9 and their endogenous tissue inhibitors in tissue remodeling after sealing of the fetal membranes in a sheep model of fetoscopic surgery.
    Devlieger R; Riley SC; Verbist L; Leask R; Pijnenborg R; Deprest JA
    J Soc Gynecol Investig; 2002; 9(3):137-45. PubMed ID: 12009387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of metalloproteinase MMP-9 and tissue inhibitor of metalloproteinase TIMP-2 in placenta of pregnant women with intrauterine growth restriction].
    Swierczewski A; Kobos J; Pasiński J; Kowalska-Koprek U; Karowicz-Bilińska A
    Ginekol Pol; 2012 Jun; 83(6):439-45. PubMed ID: 22880464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture.
    Fortunato SJ; Menon R; Lombardi SJ
    J Perinat Med; 1999; 27(5):362-8. PubMed ID: 10642956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
    Tayebjee MH; Karalis I; Nadar SK; Beevers DG; MacFadyen RJ; Lip GY
    Am J Hypertens; 2005 Mar; 18(3):325-9. PubMed ID: 15797648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitor-2 of matrix metalloproteinases (TIMP-2) in the placenta and interplacental uterine wall in normal cows and in cattle with retention of fetal membranes.
    Walter I; Boos A
    Placenta; 2001 May; 22(5):473-83. PubMed ID: 11373158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
    Lanchou J; Corbel M; Tanguy M; Germain N; Boichot E; Theret N; Clement B; Lagente V; Malledant Y
    Crit Care Med; 2003 Feb; 31(2):536-42. PubMed ID: 12576963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
    Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of matrix metalloproteinase-9/tissue inhibitors of matrix metalloproteinase -1 imbalance in maternal serum, amniotic fluid, umbilical cord serum in patients with premature rupture of the membranes].
    Lu D; Wang ZX; Wang XL; Gu XW; Wang YX; Fu D
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):20-4. PubMed ID: 16635322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum matrix metalloproteinase and tissue inhibitor of metalloproteinase concentrations in infertile women achieved pregnancy following IVF-ET.
    Shibahara H; Suzuki T; Kikuchi K; Hirano Y; Suzuki M
    Am J Reprod Immunol; 2005 Oct; 54(4):186-92. PubMed ID: 16135009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.